ReviewZeitschrift fur Gerontologie und Geriatrie2026
[Treatment of delirium with psychotropic drugs-update 2026].
Review in Zeitschrift fur Gerontologie und Geriatrie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Causal and general therapeutic measures, as well as non-pharmacological interventions are key elements in the prevention and treatment of non-substance-induced delirium. However, if certain target symptoms persist, such as delusions, hallucinations or marked agitation, there is an indication for psychopharmacotherapy, usually with antipsychotics. This narrative review provides an overview of the current state of knowledge on this topic, with particular reference to the recently published Association of the Scientific Medical Societies in Germany (AWMF) guideline, "Delirium in Older Adults". The guidline focuses on how to achieve the best possible balance between benefits and risks when using high-risk medication in vulnerable patients.
Indexed as
Identifiers
42734652What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.